Glymphatic system evaluation via magnetic resonance imaging in patients with cerebrovascular small vessel disease (CVSD)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040019

Enrollment

200

Registered

2026-04-23

Start date

2026-04-17

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I68.0 I67.88

Interventions

Group 1: Acquisition of DTI-ALPS index during routine brain MRI

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Scheduled brain MRI

Exclusion criteria

Exclusion criteria: contrainidcations against MRI

Design outcomes

Primary

Measure	Time frame
The endpoints are the DTI-ALPS index and the CAA severity score. They will be assessed using the acquired MRI sequence (DTI-ALPS index) and calculated using imaging findings and clinical parameters (CAA severity score) and correlated with one another at the time of the MRI acquisition.	—

Countries

Germany

Contacts

Public ContactUlf Jensen-Kondering

Institut für Neuroradiologie

Ulf.Jensen-Kondering@uksh.de+4945150076561

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026